Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prosthetic joint infection (PJI) is a devastating complication of knee replacement surgery. Recent evidence has shown that the burden of disease is increasing as more and more knee replacement procedures are performed. The current incidence of revision total knee replacement (TKR) for PJI is estimated at 7.5 cases per 1000 primary joint replacement procedures at 10 years. Revision TKR for PJI is complex surgery, and is associated to a high rate of post-operative complications. The 5-year patient mortality is comparable to some common cancer diagnoses, and more than 15% of patients require re-revision by 10 years. Patient-reported outcome measures (PROMs) including joint function may be worse following revision TKR for PJI than for aseptic indications. The complexity and extended length of the treatment pathway for PJI places a significant burden on the healthcare system, highlighting it as an area for future research to identify the most clinically and cost-effective interventions.

Original publication

DOI

10.1016/j.knee.2020.12.024

Type

Journal article

Journal

Knee

Publication Date

01/2021

Volume

28

Pages

417 - 421

Keywords

Arthroplasty, Epidemiology, Health-economics, Knee, Morbidity, Mortality, Patient reported outcome (PROM), Peri- prosthetic joint infection, Arthritis, Infectious, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Health Status, Humans, Prosthesis-Related Infections, Reoperation, Socioeconomic Factors